Leiden University: Platform to Accelerate Cardiac Drug Development
January 22, 2026
January 22, 2026
LEIDEN, The Netherlands, Jan. 22 -- Leiden University issued the following news:
* * *
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
Congenital cardiac arrhythm . . .
* * *
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
Congenital cardiac arrhythm . . .
